Early use of lilly GLP-1 mounjaro shows advantages in type 2 diabetes Recently diagnosed type 2 diabetes patients who did not respond well to a usual first-line treatment fared better after adding Eli Lilly's GLP-1 tirzepatide than with the addition of other drugs in the class, a study funded by the company found
Googles tool LYmph Node Assistant (303) (LYNA) can detect metastases in pathological slides with high accuracy, facilitating pathologists triaging difficult cases
However, inadequate or excessive responses can lead to malacclimatization, resulting in hypoxemia and various high-altitude illnesses, including acute mountain sickness (AMS), high-altitude cerebral edema (HACE), high-altitude pulmonary edema (HAPE), chronic mountain sickness (CMS), and high-altitude pulmonary hypertension (HAPH)
There are no patent royalties (Novo Nordisk holds patent protection through 2032)
The body naturally metabolizes and clears peptides over time